{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:04:37Z","timestamp":1791212677693,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG062514"],"award-info":[{"award-number":["R01AG062514"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R21AG063068"],"award-info":[{"award-number":["R21AG063068"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG058469"],"award-info":[{"award-number":["RF1AG058469"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG059319"],"award-info":[{"award-number":["RF1AG059319"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U01AG046139"],"award-info":[{"award-number":["U01AG046139"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U01AG061835"],"award-info":[{"award-number":["U01AG061835"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.coph.2021.06.012","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T19:10:39Z","timestamp":1627931439000},"page":"59-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Systems modeling of metabolic dysregulation in neurodegenerative diseases"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3382-4941","authenticated-orcid":false,"given":"Priyanka","family":"Baloni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5229-9011","authenticated-orcid":false,"given":"Cory C.","family":"Funk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4353-9965","authenticated-orcid":false,"given":"Ben","family":"Readhead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan D.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2021.06.012_bib1","article-title":"A\u00a0comparative, correlate analysis and projection of global and regional life expectancy, healthy life expectancy, and their GAP: 1995-2025","volume":"10","author":"Cao","year":"2020","journal-title":"J\u00a0Glob Health"},{"key":"10.1016\/j.coph.2021.06.012_bib2","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0140-6736(20)30977-6","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2021.06.012_bib3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/alz.12328","article-title":"2021 Alzheimer's disease facts and figures","volume":"17","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.coph.2021.06.012_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41531-018-0058-0","article-title":"Prevalence of Parkinson's disease across North America","volume":"4","author":"Marras","year":"2018","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.coph.2021.06.012_bib5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.coph.2021.06.012_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.arr.2014.01.004","article-title":"Ageing and Parkinson's disease: why is advancing age the biggest risk factor?","volume":"14","author":"Reeve","year":"2014","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.coph.2021.06.012_bib7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1089\/neu.2014.3506","article-title":"Aging, neurodegenerative disease, and traumatic brain injury: the role of neuroimaging","volume":"32","author":"Esopenko","year":"2015","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.coph.2021.06.012_bib8","series-title":"StatPearls","article-title":"Alzheimer disease","author":"Kumar","year":"2020"},{"key":"10.1016\/j.coph.2021.06.012_bib9","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1073\/pnas.1913904117","article-title":"The process of Lewy body formation, rather than simply \u03b1-synuclein fibrillization, is one of the major drivers of neurodegeneration","volume":"117","author":"Mahul-Mellier","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2021.06.012_bib10","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/mdc3.13148","article-title":"Disease onset in Huntington's disease: when is the conversion?","volume":"8","author":"Oosterloo","year":"2021","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.coph.2021.06.012_bib11","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.cmet.2018.05.011","article-title":"Hallmarks of brain aging: adaptive and pathological modification by metabolic states","volume":"27","author":"Mattson","year":"2018","journal-title":"Cell Metabol"},{"key":"10.1016\/j.coph.2021.06.012_bib12","doi-asserted-by":"crossref","first-page":"664","DOI":"10.2174\/1570159X15666170823095628","article-title":"In silico studies in drug research against neurodegenerative diseases","volume":"16","author":"Makhouri","year":"2018","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.coph.2021.06.012_bib13","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1021\/acs.analchem.6b04278","article-title":"Analytical techniques in neuroscience: recent advances in imaging, separation, and electrochemical methods","volume":"89","author":"Ganesana","year":"2017","journal-title":"Anal Chem"},{"key":"10.1016\/j.coph.2021.06.012_sref14","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3389\/fnins.2020.00716","article-title":"Systems biology approaches to understand the host-microbiome interactions in neurodegenerative diseases","volume":"14","author":"Rosario","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1016\/j.coph.2021.06.012_bib15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fnagi.2019.00130","article-title":"The gut-brain\u00a0Axis in neurodegenerative diseases and relevance of\u00a0the canine model: a review","volume":"11","author":"Ambrosini","year":"2019","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.coph.2021.06.012_sref16","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-21330-0","article-title":"Machine learning identifies candidates for drug repurposing in Alzheimer's disease","volume":"12","author":"Rodriguez","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2021.06.012_bib17","doi-asserted-by":"crossref","DOI":"10.4324\/9781315373669-12","article-title":"Promising candidates for drug repurposing in Huntington's disease","author":"Fusco","year":"2017","journal-title":"Drug Repositioning"},{"key":"10.1016\/j.coph.2021.06.012_bib18","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4939-9039-9","article-title":"Using drug expression profiles and machine learning approach for drug repurposing","author":"Zhao","year":"2019","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.coph.2021.06.012_bib19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.coph.2021.06.012_bib20","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.bbadis.2016.06.015","article-title":"Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in Neurodegeneration","volume":"1863","author":"Jha","year":"2017","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"key":"10.1016\/j.coph.2021.06.012_bib21","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-28637-2_5","article-title":"Mitochondrial signaling and neurodegeneration","author":"Picard","year":"2016","journal-title":"Mitochondrial Dysfunct Neurodegener Disord"},{"key":"10.1016\/j.coph.2021.06.012_bib22","series-title":"Mitochondrial dysfunction in neurodegenerative disorders","author":"Reeve","year":"2011"},{"key":"10.1016\/j.coph.2021.06.012_sref23","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-019-1730-3","article-title":"Current status and applications of genome-scale metabolic models","volume":"20","author":"Gu","year":"2019","journal-title":"Genome Biol"},{"key":"10.1016\/j.coph.2021.06.012_bib24","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1042\/EBC20180011","article-title":"Integrating \u2013omics data into genome-scale metabolic network models: principles and challenges","volume":"62","author":"Ramon","year":"2018","journal-title":"Essays Biochem"},{"key":"10.1016\/j.coph.2021.06.012_bib25","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41596-018-0098-2","article-title":"Creation and analysis of biochemical constraint-based models using the COBRA Toolbox v.3.0","volume":"14","author":"Heirendt","year":"2019","journal-title":"Nat Protoc"},{"key":"10.1016\/j.coph.2021.06.012_sref26","doi-asserted-by":"crossref","first-page":"100138","DOI":"10.1016\/j.xcrm.2020.100138","article-title":"Metabolic network analysis reveals altered bile acid synthesis and metabolism in Alzheimer's disease","volume":"1","author":"Baloni","year":"2020","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.coph.2021.06.012_bib27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1752-0509-6-153","article-title":"Reconstruction of genome-scale metabolic models for 126 human tissues using mCADRE","volume":"6","author":"Wang","year":"2012","journal-title":"BMC Syst Biol"},{"key":"10.1016\/j.coph.2021.06.012_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240953","article-title":"Genome-scale reconstructions to assess metabolic phylogeny and organism clustering","volume":"15","author":"Schulz","year":"2020","journal-title":"PloS One"},{"issue":"10","key":"10.1016\/j.coph.2021.06.012_bib29","doi-asserted-by":"crossref","first-page":"1900519","DOI":"10.1002\/biot.201900519","article-title":"Pan-genome-scale network reconstruction: harnessing phylogenomics increases the quantity and quality of metabolic models","volume":"15","author":"Correia","year":"2020","journal-title":"Biotechnol J"},{"key":"10.1016\/j.coph.2021.06.012_bib30","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/nbt.1711","article-title":"Large-scale in silico modeling of metabolic interactions between cell types in the human brain","volume":"28","author":"Lewis","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.coph.2021.06.012_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fnagi.2017.00023","article-title":"Genome-scale reconstruction of the human astrocyte metabolic network","volume":"9","author":"Mart\u00edn-Jim\u00e9nez","year":"2017","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.coph.2021.06.012_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006867","article-title":"Increasing consensus of context-specific metabolic models by integrating data-inferred cell functions","volume":"15","author":"Richelle","year":"2019","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.coph.2021.06.012_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41593-018-0286-y","article-title":"Role of astrocytes, microglia, and tanycytes in brain control of systemic metabolism","volume":"22","author":"Garc\u00eda-C\u00e1ceres","year":"2019","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.coph.2021.06.012_bib34","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.celrep.2019.10.035","article-title":"Integrated analyses of microbiome and longitudinal metabolome data reveal microbial-host interactions on sulfur metabolism in Parkinson's disease","volume":"29","author":"Hertel","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.coph.2021.06.012_sref35","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jalz.2018.07.217","article-title":"Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome","volume":"15","author":"MahmoudianDehkordi","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.coph.2021.06.012_sref36","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.1038\/s41467-020-19473-7","article-title":"Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's disease","volume":"11","author":"Huynh","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2021.06.012_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074341","article-title":"Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes","volume":"8","author":"Meikle","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.coph.2021.06.012_bib38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/19490976.2019.1638722","article-title":"Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health","volume":"11","author":"Parker","year":"2020","journal-title":"Gut Microb"},{"key":"10.1016\/j.coph.2021.06.012_sref39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12915-020-00775-7","article-title":"Parkinson's disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions","volume":"18","author":"Baldini","year":"2020","journal-title":"BMC Biol"},{"key":"10.1016\/j.coph.2021.06.012_sref40","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.tins.2020.10.002","article-title":"Microglial phagocytosis: a disease-associated process emerging from Alzheimer's disease genetics","volume":"43","author":"Podle\u015bny-Drabiniok","year":"2020","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.coph.2021.06.012_bib41","article-title":"Largest GWAS (N=1,126,563) of Alzheimer\u2019s disease implicates microglia and immune cells","author":"Wightman","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.coph.2021.06.012_bib42","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1101\/gad.289140.116","article-title":"Undercover: gene control by metabolites and metabolic enzymes","volume":"30","author":"van der Knaap","year":"2016","journal-title":"Genes Dev"},{"key":"10.1016\/j.coph.2021.06.012_bib43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pscychresns.2016.10.001","article-title":"SREBF-2 polymorphism influences white matter microstructure in bipolar disorder","volume":"257","author":"Poletti","year":"2016","journal-title":"Psychiatry Res Neuroimaging"},{"key":"10.1016\/j.coph.2021.06.012_bib44","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/mp.2008.110","article-title":"Polymorphisms in SREBF1 and SREBF2 , two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples","volume":"15","author":"Le Hellard","year":"2008","journal-title":"Mol Psychiatr"},{"key":"10.1016\/j.coph.2021.06.012_bib45","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1093\/hmg\/ddq079","article-title":"Analysis of lipid pathway genes indicates association of sequence variation near SREBF1\/TOM1L2\/ATPAF2 with dementia risk","volume":"19","author":"Reynolds","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.coph.2021.06.012_bib46","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/nn.4587","article-title":"A\u00a0common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease","volume":"20","author":"Huang","year":"2017","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.coph.2021.06.012_sref47","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cels.2019.01.002","article-title":"Genome-scale transcriptional regulatory network models of psychiatric and neurodegenerative disorders","volume":"8","author":"Pearl","year":"2019","journal-title":"Cell Syst"},{"key":"10.1016\/j.coph.2021.06.012_sref48","doi-asserted-by":"crossref","first-page":"108029","DOI":"10.1016\/j.celrep.2020.108029","article-title":"Atlas of transcription factor binding sites from ENCODE DNase hypersensitivity data across 27 tissue types","volume":"32","author":"Funk","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.coph.2021.06.012_bib49","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20167435","article-title":"Transcriptional regulatory networks underlying gene expression changes in Huntington's disease","volume":"14","author":"Ament","year":"2018","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.coph.2021.06.012_bib50","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1038\/s41467-018-05379-y","article-title":"Evaluation of chromatin accessibility in prefrontal cortex of individuals with schizophrenia","volume":"9","author":"Bryois","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2021.06.012_bib51","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1101\/gr.232488.117","article-title":"An atlas of chromatin accessibility in the adult human brain","volume":"28","author":"Fullard","year":"2018","journal-title":"Genome Res"},{"key":"10.1016\/j.coph.2021.06.012_bib52","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2967\/jnumed.117.206300","article-title":"The network degeneration hypothesis: spread of neurodegenerative patterns along neuronal brain networks","volume":"59","author":"Drzezga","year":"2018","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.coph.2021.06.012_sref53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-17405-z","article-title":"Multiscale causal networks identify VGF as a key regulator of Alzheimer's disease","volume":"11","author":"Beckmann","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2021.06.012_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12859-019-3101-1","article-title":"Quantifying mechanisms in neurodegenerative diseases (NDDs) using candidate mechanism perturbation amplitude (CMPA) algorithm","volume":"20","author":"Karki","year":"2019","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.coph.2021.06.012_bib55","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3390\/pr7120940","article-title":"Theoretical and experimental approaches aimed at drug design targeting neurodegenerative diseases","volume":"7","author":"Morales-Navarro","year":"2019","journal-title":"Processes"},{"key":"10.1016\/j.coph.2021.06.012_bib56","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/bcpt.13075","article-title":"Neuroinformatics and computational modelling as complementary tools for neurotoxicology studies","volume":"123","author":"Linne","year":"2018","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.coph.2021.06.012_bib57","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","article-title":"Applications of machine learning in drug discovery and development","volume":"18","author":"Vamathevan","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.coph.2021.06.012_sref58","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb5398","article-title":"Molecular subtyping of Alzheimer's disease using RNA sequencing data reveals novel mechanisms and targets","volume":"7","author":"Neff","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.coph.2021.06.012_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-021-01309-6","article-title":"Four distinct trajectories of tau deposition identified in Alzheimer's disease","author":"Vogel","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.coph.2021.06.012_sref60","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1038\/s41467-020-19622-y","article-title":"Molecular estimation of neurodegeneration pseudotime in older brains","volume":"11","author":"Mukherjee","year":"2020","journal-title":"Nat Commun"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489221000850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489221000850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:54:57Z","timestamp":1761461697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489221000850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":60,"alternative-id":["S1471489221000850"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2021.06.012","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systems modeling of metabolic dysregulation in neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2021.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}